Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of temozolomide in patient
with relapsed or advanced anaplastic oligodendroglioma and anaplastic oligoastrocytoma.